BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21737236)

  • 1. Relationship between the timing of administration of IgM and IgA enriched immunoglobulins in patients with severe sepsis and septic shock and the outcome: a retrospective analysis.
    Berlot G; Vassallo MC; Busetto N; Bianchi M; Zornada F; Rosato I; Tartamella F; Prisco L; Bigotto F; Bigolin T; Ferluga M; Batticci I; Michelone E; Borelli M; Viviani M; Tomasini A
    J Crit Care; 2012 Apr; 27(2):167-71. PubMed ID: 21737236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with polyclonal IgM-enriched immunoglobulins in a group of patients affected by sepsis after cardiac surgery.
    Buda S; Riefolo A; Biscione R; Goretti E; Cattabriga I; Grillone G; Bacchi-Reggiani L; Pacini D
    J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):440-5. PubMed ID: 16085247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose immunoglobulin G is not associated with mortality in patients with sepsis and septic shock.
    Iizuka Y; Sanui M; Sasabuchi Y; Lefor AK; Hayakawa M; Saito S; Uchino S; Yamakawa K; Kudo D; Takimoto K; Mayumi T; Azuhata T; Ito F; Yoshihiro S; Hayakawa K; Nakashima T; Ogura T; Noda E; Nakamura Y; Sekine R; Yoshikawa Y; Sekino M; Ueno K; Okuda Y; Watanabe M; Tampo A; Saito N; Kitai Y; Takahashi H; Kobayashi I; Kondo Y; Matsunaga W; Nachi S; Miike T; Takahashi H; Takauji S; Umakoshi K; Todaka T; Kodaira H; Andoh K; Kasai T; Iwashita Y; Arai H; Murata M; Yamane M; Shiga K; Hori N
    Crit Care; 2017 Jul; 21(1):181. PubMed ID: 28701223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the timing of administration of IgM- and IgA-enriched intravenous polyclonal immunoglobulins on the outcome of septic shock patients.
    Berlot G; Vassallo MC; Busetto N; Nieto Yabar M; Istrati T; Baronio S; Quarantotto G; Bixio M; Barbati G; Dattola R; Longo I; Chillemi A; Scamperle A; Iscra F; Tomasini A
    Ann Intensive Care; 2018 Dec; 8(1):122. PubMed ID: 30535962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of immunoglobulin M-enriched immunoglobulin (Pentaglobin) in the treatment of severe sepsis and septic shock.
    Neilson AR; Burchardi H; Schneider H
    J Crit Care; 2005 Sep; 20(3):239-49. PubMed ID: 16253792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adequate antibiotic therapy prior to ICU admission in patients with severe sepsis and septic shock reduces hospital mortality.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Fernández-Delgado E; López-Sánchez JM
    Crit Care; 2015 Aug; 19(1):302. PubMed ID: 26307060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.
    Ferrer R; Martin-Loeches I; Phillips G; Osborn TM; Townsend S; Dellinger RP; Artigas A; Schorr C; Levy MM
    Crit Care Med; 2014 Aug; 42(8):1749-55. PubMed ID: 24717459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulins IgG1, IgM and IgA: a synergistic team influencing survival in sepsis.
    Bermejo-Martín JF; Rodriguez-Fernandez A; Herrán-Monge R; Andaluz-Ojeda D; Muriel-Bombín A; Merino P; García-García MM; Citores R; Gandía F; Almansa R; Blanco J;
    J Intern Med; 2014 Oct; 276(4):404-12. PubMed ID: 24815605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G; Dimastromatteo G
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis.
    Turgeon AF; Hutton B; Fergusson DA; McIntyre L; Tinmouth AA; Cameron DW; Hébert PC
    Ann Intern Med; 2007 Feb; 146(3):193-203. PubMed ID: 17283351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of pentaglobin therapy on prognosis in patients with severe sepsis].
    Tuğrul S; Ozcan PE; Akinci O; Cağatay A; Cakar N; Esen F
    Ulus Travma Derg; 2001 Oct; 7(4):219-23. PubMed ID: 11705075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock.
    Garnacho-Montero J; Gutiérrez-Pizarraya A; Escoresca-Ortega A; Corcia-Palomo Y; Fernández-Delgado E; Herrera-Melero I; Ortiz-Leyba C; Márquez-Vácaro JA
    Intensive Care Med; 2014 Jan; 40(1):32-40. PubMed ID: 24026297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of etomidate in severe sepsis and septic shock.
    Dmello D; Taylor S; O'Brien J; Matuschak GM
    Chest; 2010 Dec; 138(6):1327-32. PubMed ID: 20651024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality in Patients With Septic Shock by Multidrug Resistant Bacteria: Risk Factors and Impact of Sepsis Treatments.
    Busani S; Serafini G; Mantovani E; Venturelli C; Giannella M; Viale P; Mussini C; Cossarizza A; Girardis M
    J Intensive Care Med; 2019 Jan; 34(1):48-54. PubMed ID: 28100110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
    Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
    Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock.
    Yoo JW; Lee JR; Jung YK; Choi SH; Son JS; Kang BJ; Park TS; Huh JW; Lim CM; Koh Y; Hong SB
    Korean J Intern Med; 2015 Jul; 30(4):471-7. PubMed ID: 26161013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery.
    Rodríguez A; Rello J; Neira J; Maskin B; Ceraso D; Vasta L; Palizas F
    Shock; 2005 Apr; 23(4):298-304. PubMed ID: 15803051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluid balance in sepsis and septic shock as a determining factor of mortality.
    Sirvent JM; Ferri C; Baró A; Murcia C; Lorencio C
    Am J Emerg Med; 2015 Feb; 33(2):186-9. PubMed ID: 25483379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.